Cardiorespiratory Response During Whole Body Vibration Training in Patients With Chronic Lung Disease

NCT01898143 | Completed

• 1 other identifier: SpiroErgoGalileo-2013
• Study Type: interventional
• Target: 10
• Locations: 1 country
• Sites: 1

Brief Summary

Whole body vibration training seems to be a useful adjunct in exercise training in patients with severe COPD. The basic principle relies on reflectory muscle contractions caused by a vibration stimulus. Until now the impact of whole body vibration training on cardiopulmonary parameters remained unknown. Therefore aim of this study is to investigate cardiopulmonary parameters during whole body vibration training in patients with chronic lung disease.

Conditions

Chronic Obstructive Lung Disease (n=10); Interstitial Lung Disease (n=10)

Keywords

Whole body vibration, cardiorespiratory response

Outcome Measures

Primary Outcomes (1)

• peak oxygen consumption (VO2 peak)

  subjects perform several short bouts (1 to 3 minutes duration) of squatting exercise with or without whole body vibration. The peak values of each single part is used for comparison.

  during 1 exercise session

Secondary Outcomes (6)

• heart rate (HR)

  during 1 exercise session

• minute ventilation (VE)

  during 1 exercise session

• perceived exertion for dyspnea and leg fatigue (Borg-scale)

  during 1 exercise session

• Alveolar-arterial oxygen difference (AaDO2)

  during 1 exercise session

• breathing frequency (BF)

  during 1 exercise session

Study Arms (2)

Whole body vibration in COPD

OTHER

Patients with COPD GOLD III or IV

Other: Whole body vibration

Whole body vibration in ILD

OTHER

PAtients with interstitial lung disease

Other: Whole body vibration

Interventions

Whole body vibration OTHER

Whole body vibration in COPD; Whole body vibration in ILD

Eligibility Criteria

• Age: 20 Years - 75 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• COPD stage III or IV according to the Global Initiative for chronic obstructive lung disease \[GOLD\])
• Interstitial Lung disease (forced vital capacity (FVC) \< 70% pred., diffusion capacity of lung for carbon monoxide (DLCO) 30-70% pred.)

You may not qualify if:

• Oxygen therapy during exercise required
• Severe exacerbation of lung disease, with necessity of change in medication or persistent symptoms \> 3days
• activated arthrosis /arthropathy/ rheumatoid Arthritis/ acute discopathy
• acute thrombosis
• acute musculoskeletal inflammation
• Epilepsy
• Gallstones

Sponsors & Collaborators

• Schön Klinik Berchtesgadener Land: lead

Study Sites (1)

Schön Klinik Berchtesgadener Land

Schönau am Königssee, 83471, Germany

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive; Lung Diseases, Interstitial

Condition Hierarchy (Ancestors)

Lung Diseases, Obstructive; Lung Diseases; Respiratory Tract Diseases; Chronic Disease; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NON RANDOMIZED
• Masking: SINGLE
• Who Masked: OUTCOMES ASSESSOR
• Purpose: DIAGNOSTIC
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Head Physican (department of pneumology)

Study Record Dates

• First Submitted: June 24, 2013
• First Posted: July 12, 2013
• Study Start: June 1, 2013
• Primary Completion: May 1, 2015
• Study Completion: May 1, 2015
• Last Updated: February 24, 2016

Record last verified: 2016-02

Locations

DE (1)